The Union Ministry of Health and Family Welfare has introduced significant amendments to the Medical Devices Rules, 2017, aimed at enhancing the Ease of Doing Business (EoDB) and accelerating market access for advanced medical technologies. The regulatory updates streamline compliance requirements, reduce administrative overhead, and establish standardized testing processes to lower costs for domestic manufacturers and importers while maintaining strict quality and safety standards.
A major highlight of the reform is the update to Rule 44, which eliminates loan licensing requirements for outsourced sterilization activities. Under the new provision, medical device manufacturers utilizing third-party sterilization facilities that already possess a valid license under the 2017 rules will no longer need to obtain a separate loan license. This change removes redundant administrative procedures, cuts operational costs, and minimizes manufacturing delays—particularly benefiting businesses without in-house sterilization infrastructure. To ensure a smooth operational transition, the Ministry has incorporated a six-month grace period for manufacturers to update their product packaging and labeling.
Additionally, the Ministry has amended Rule 63 to include the European Union (EU) in its list of recognized stringent regulatory jurisdictions, joining the United States, the United Kingdom, Australia, Canada, and Japan. This expansion allows medical devices without predicate devices that are already approved within the EU to qualify for clinical investigation waivers in India. By aligning domestic standards with international regulatory frameworks, these amendments facilitate quicker market entry for innovative medical solutions, ensuring Indian patients gain timely access to cutting-edge healthcare technologies.
Nurturing Creativity – Keekli Charitable Trust, Shimla
